Catalyst Wire Dossier Catalyst Wire Dossier

Umbilical Cord Blood enriched with Platelet Plasma

· Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Umbilical Cord Blood enriched with Platelet Plasma, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma. [NA]

See pricing